Search

everythinglearnresearchcommunity

for

Search:↓

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

New anti-acne medications are being tested to offer alternatives to current treatments.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The project highlights the importance of early diagnosis and patient advocacy in managing Systemic Lupus Erythematosus.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

SVF is safe and effective, but research quality is low; new guidelines are proposed to improve future studies.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The treatment was ineffective in humans.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

The assay effectively identifies compounds that affect immune cell activation.